Researcher at the Institute de Biodiversidad y Aplicaciones en Salud (IBAS) and the Hospital Universitario San Ignacio - Pontificia Universidad Javeriana, where he also serves as a mentor in the Oncology Research Training Program. He is a PhD candidate in Biological Sciences and holds master's degrees in Biological and Economic Sciences, enabling him to integrate biomedical research with economic evaluation and health impact analysis. His career has focused on clinical pharmacology, translational medicine, network pharmacology, and phytomedicines, leading innovative projects in oncology and infectious diseases. His experience includes coordinating preclinical and Phase I/II clinical studies, assessing the safety and efficacy of phytomedicines, as well as the development of biosimilars and oncology pharmacy initiatives. In addition, he has served as a scientific advisor for pharmaceutical companies in pharmaceutical technology and therapeutic innovation, contributing to the design and validation of strategies for drug development, clinical safety, and pharmacoeconomics. He currently leads Real World Evidence (RWE) projects for pharmaceutical companies, with a focus on clinical outcomes, comparative effectiveness, and evaluation of therapeutic impact in real-world medical practice.